Komipharm International Co Ltd
KOSDAQ:041960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Komipharm International Co Ltd
KOSDAQ:041960
|
KR |
|
S
|
Sumitomo Pharma Co Ltd
SWB:DPM
|
JP |
|
P
|
PROG Holdings Inc
F:AZD
|
US |
|
Agora Inc
NASDAQ:API
|
US |
|
Talgo SA
F:XTG
|
ES |
Intrinsic Value
Is Komipharm International Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Komipharm International Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Komipharm International Co Ltd looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with Komipharm International Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Komipharm International Does
Komipharm International is a South Korean pharmaceutical company that develops and sells medicines and health products for animals, and also works in some human drug and biotech-related areas. Its business centers on making finished products such as veterinary drugs, drug ingredients, and other life-science products that help treat or prevent disease.
- Headquarters
- Korea KR
- Employees
- 161
- IPO date
- Oct 30, 2001
Revenue & Expenses Breakdown
Komipharm International Co Ltd
Earnings Waterfall
Komipharm International Co Ltd
The intrinsic value for Komipharm International Co Ltd (041960) under the Base Case is hidden KRW.
Compared with the current market price of 8 620 KRW, the stock appears hidden.